Pyrrole-2, 5dione derivatives and their used as GSK-3...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S547000, C546S184000

Reexamination Certificate

active

07405305

ABSTRACT:
The present invention provides kinase inhibitors of Formula (I)

REFERENCES:
patent: 5057614 (1991-10-01), Davis et al.
patent: 5721245 (1998-02-01), Davis et al.
patent: 6153641 (2000-11-01), Bergstrand et al.
patent: 2005/0090483 (2005-04-01), Engler et al.
patent: WO98/16528 (1998-04-01), None
patent: WO 00/38675 (2000-07-01), None
patent: WO01/44235 (2001-06-01), None
patent: WO01/44247 (2001-06-01), None
patent: WO 02/10158 (2002-02-01), None
patent: WO02/46183 (2002-06-01), None
patent: WO02/46197 (2002-06-01), None
FDA mulls drug to slow late-stage Alzheimer's [online],[retrieved on Sep. 23, 2003].Retrieved from the Internet, URL; http://www.cnn.com/2003/HEALTH/conditions/09/24/alzheimers.drug.ap/indexhtml>.
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 1992-1996.
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 2050-2057.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrole-2, 5dione derivatives and their used as GSK-3... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrole-2, 5dione derivatives and their used as GSK-3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrole-2, 5dione derivatives and their used as GSK-3... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2805381

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.